Evans’ Syndrome, myelofibrosis and systemic lupus erythematosus: Role of procollagens in myelofibrosis

Pathology

Volumn 27, Issue 3, 1995, Pages 255-259

  Ramakrishna, R ^a   Kyle, P W ^a   Day, P J ^a   Manoharan, A ^a  

^a ST GEORGE HOSPITAL   (Australia)

Author keywords

Myelofibrosis; Procollagens; SLE

Indexed keywords

ANTIINFLAMMATORY AGENT; COLCHICINE; DANAZOL; GLUCOCORTICOID; IMMUNOGLOBULIN; PREDNISOLONE; PROCOLLAGEN; VINCRISTINE;

ADULT; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD CELL COUNT; BONE MARROW EXAMINATION; CASE REPORT; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; MYELOFIBROSIS; PATHOGENESIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA;

ADOLESCENT; ANEMIA, HEMOLYTIC, AUTOIMMUNE; BIOLOGICAL MARKERS; CASE REPORT; FEMALE; HUMAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MYELOFIBROSIS; PROCOLLAGEN; THROMBOCYTOPENIA;

EID: 0028856330     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313029500169073     Document Type: Article

References (23)

1. Schur PH. Clinical features of SLE. In: Kelley WN, Harris Jr ED, Ruddy S et al., eds. Textbook of Rheumatology, 3rd edn. Place??: WB Saunders, 1989; 1101-29.
2. Rosen PJ, Cramer AD, Dubois EL et al. Systemic lupus erythema- tosis and myelofibrosis: A possible pathogenetic relationship. Clin Res (Abst) 1973; 21: 565a.
3. Lau KS, White JC. Myelosclerosis associated with systemic lupus erythematosis in patients in West Malaysia. J Clin Pathol 1969; 22: 433-8.
4. Cavalant J, Shadduck RK, Winkelstein A et al. Red-cell hypoplasia and increased bone marrow reticulin in systemic lupus erythema- tosis: Reversal with corticosteroid therapy. Am J Haematol 1978; 253-63.
5. Daly HM, Scott GL. Myelofibrosis as a cause of pancytopenia in systemic lupus erythematosis. J Clin Pathol 1982; 36: 1219-22.
6. Nanji AA, Jetha N. Myelofibrosis as a cause of pancytopenia in systemic lupus erythematosis (letter). J Clin Pathol 1984; 37: 714.
7. Kaelin WG, Spivak JL. Systemic lupus erythematosis and myelofibrosis. Am J Med 1986; 81: 935-8.
8. Matsouka C, Liouris J, Adrianakos A et al. Systemic lupus erythematosis and myelofibrosis, Medicine 1994.
9. Paquette RL, Meshkinpour A, Rosen PJ. Autoimmune myelofibrosis. A steroid-responsive cause of bone marrow fibrosis associated with systemic lupus erythematosus. Medicine 1994; 73: 145-52.
10. Kiefel V, Santoso S, Weisheit M et al. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): A new tool for the identification of platelet-reactive antibodies. Blood 1987; 70: 1722-6.
11. Feng C, Ng MHL, Szeto RSC et al. Bone marrow findings in lupus patients with pancytopenia. Pathology 1991; 23: 5-7.
12. McCarthy DM. Fibrosis of the bone marrow: Content and causes (annotation). Br J Haematol 1985; 89: 1-7.
13. Reilly JT, Barnett D, Dolan G et al. Characterization of an acute micromegakaryocytic leukemia: Evidence for the pathogenesis of myelofibrosis. Br J Haematol 1993; 83: 58-63.
14. Gordon BR, Coleman M, Kohen P et al. Immunologic abnormalities in myelofibrosis with activation of the complement system. Blood 1981; 58: 904-10.
15. Rozman C, Corrons JLV, Nieto LH et al. Idiopathic myelofibrosis: A possible role of immunological phenomenon. Br J Haematol 1982; 50: 375-80.
16. Cappio FG, Vigliani R, Novarine A et al. Idiopathic myelofibrosis: a possible role for immune complexes in the pathogenesis of bone marrow fibrosis. Br J Haematol 1981; 49: 17-21.
17. Lewis CM, Pegrum GD. Immune complexes in myelofibrosis: a possible guide to management. Br J Haematol 1978; 39: 233-9.
18. Hochweiss S, Fruchtman S, Hahn EG et al. Increased serum procollagen III aminotermxnal peptide in myelofibrosis. Am j Haematol 1983; 15: 343-51.
19. Hasslebach H, Junder P, Hossler-Peterson K et al. Procollagen type III aminoterminal peptide in serum in idiopathic myelofibrosis and allied conditions: relation to disease activity and effect of chemotherapy. Am J Haematol 1990; 33: 18-26.
20. Prockop DJ, Kivirikko KI, Tuderman L et al. The biosynthesis of collagen and its disorders. N Engl J Med 1979; 301: 77-83.
21. Owellen RJ, Owens AH, Donigian DW. The binding of vincristine, vinblastine and colchicine to tubulin. Biochemical and Biophysical Research Communications 1972; 47: 685-91.
22. Manoharan A, Horsley R, Pitney WR. The reticulin content of bone marrow in acute leukemia in adults. Br J Haematol 1979; 43:185-90.
23. Manoharan A, Pitney WR. Chemotherapy resolves symptoms and reverses marrow fibrosis in myelofibrosis. Scand J Haematol 1984; 33: 453-9.